Positrigo ready for the commercialisation phase after raising CHF 5.5 million

Existing and new investors have contributed to Positrigo’s series B financing round to enable the company to finalise market approvals in Europe and the US of its first product and to start commercialisation. The startup is developing nuclear medical imaging devices to advance functional imaging.
Read the full article at Startupticker